                </a></li></ul></div><p><strong>Figure 5.  <span>Requirement of TORC1 for L-LTP in hippocampal slices.</span></strong></p><a id="article1.body1.sec2.sec5.fig1.caption1.p1" name="article1.body1.sec2.sec5.fig1.caption1.p1"></a><p>(A) Representative picture of EGFP infected slice used in electrophysiological recordings.</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p2" name="article1.body1.sec2.sec5.fig1.caption1.p2"></a><p>Scale bar: 100 µm.</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p3" name="article1.body1.sec2.sec5.fig1.caption1.p3"></a><p>(B) Statistical analysis of input-output ratio from control slices and slices infected with DN-TORC1 or WT-TORC1.</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p4" name="article1.body1.sec2.sec5.fig1.caption1.p4"></a><p>(C) DN-TORC1 but not EGFP infection blocked the maintenance of L-LTP as compared with EGFP infected slices and non-infected control slices (percent baseline, at 3 h, DN-TORC1  =  109.2% ± 6.5 vs EGFP  =  178.3 ± 10.2 and Control  =  176.9 % ± 13.4).</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p5" name="article1.body1.sec2.sec5.fig1.caption1.p5"></a><p>(D) WT-TORC1 infection switched E-LTP into L-LTP, DN-TORC1 infection did not affect E-LTP (at 3 h, WT-TORC1  =  145.6 % ± 10.7 vs Control  =  102.8 % ± 6.2 and DN-TORC1  =  103.0 ± 7.5).</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p6" name="article1.body1.sec2.sec5.fig1.caption1.p6"></a><p>Scale bar: 300 µV, 10 ms.</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p7" name="article1.body1.sec2.sec5.fig1.caption1.p7"></a><p>In both (C) and (D), representative fEPSP traces taken at the times indicated (1 and 2) are shown at top, arrows indicate the time of HFS.</p>
<span>THISISTHEEND
